Cargando…

Clinical features of Pompe disease

Glycogen storage disease type II - also called Pompe disease or acid maltase deficiency - is an autosomal recessive metabolic disorder, caused by an accumulation of glycogen in the lysosome due to deficiency of the lysosomal acid alpha-glucosidase enzyme. Pompe disease is transmitted as an autosomal...

Descripción completa

Detalles Bibliográficos
Autores principales: MANGANELLI, FIORE, RUGGIERO, LUCIA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pacini Editore SpA 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866902/
https://www.ncbi.nlm.nih.gov/pubmed/24399863
_version_ 1782296241591287808
author MANGANELLI, FIORE
RUGGIERO, LUCIA
author_facet MANGANELLI, FIORE
RUGGIERO, LUCIA
author_sort MANGANELLI, FIORE
collection PubMed
description Glycogen storage disease type II - also called Pompe disease or acid maltase deficiency - is an autosomal recessive metabolic disorder, caused by an accumulation of glycogen in the lysosome due to deficiency of the lysosomal acid alpha-glucosidase enzyme. Pompe disease is transmitted as an autosomal recessive trait and is caused by mutations in the gene encoding the acid α-glucosidase (GAA), located on chromosome 17q25.2-q25.3. The different disease phenotypes are related to the levels of residual GAA activity in muscles. The clinical spectrum ranging from the classical form with early onset and severe phenotype to not-classical form with later onset and milder phenotype is described.
format Online
Article
Text
id pubmed-3866902
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Pacini Editore SpA
record_format MEDLINE/PubMed
spelling pubmed-38669022014-01-07 Clinical features of Pompe disease MANGANELLI, FIORE RUGGIERO, LUCIA Acta Myol Original Articles Glycogen storage disease type II - also called Pompe disease or acid maltase deficiency - is an autosomal recessive metabolic disorder, caused by an accumulation of glycogen in the lysosome due to deficiency of the lysosomal acid alpha-glucosidase enzyme. Pompe disease is transmitted as an autosomal recessive trait and is caused by mutations in the gene encoding the acid α-glucosidase (GAA), located on chromosome 17q25.2-q25.3. The different disease phenotypes are related to the levels of residual GAA activity in muscles. The clinical spectrum ranging from the classical form with early onset and severe phenotype to not-classical form with later onset and milder phenotype is described. Pacini Editore SpA 2013-10 /pmc/articles/PMC3866902/ /pubmed/24399863 Text en The journal and the individual contributions contained in it are protected by the copyright of Gaetano Conte Academy, Naples, Italy http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License, which permits for noncommercial use, distribution, and reproduction in any digital medium, provided the original work is properly cited and is not altered in any way. For details, please refer to http://creativecommons.org/licenses/by-nc-nd/3.0/
spellingShingle Original Articles
MANGANELLI, FIORE
RUGGIERO, LUCIA
Clinical features of Pompe disease
title Clinical features of Pompe disease
title_full Clinical features of Pompe disease
title_fullStr Clinical features of Pompe disease
title_full_unstemmed Clinical features of Pompe disease
title_short Clinical features of Pompe disease
title_sort clinical features of pompe disease
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866902/
https://www.ncbi.nlm.nih.gov/pubmed/24399863
work_keys_str_mv AT manganellifiore clinicalfeaturesofpompedisease
AT ruggierolucia clinicalfeaturesofpompedisease